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Many bacteria and archaea possess a cell surface layer ʹ S-layer ʹ made of a two-29 
dimensional protein array that covers the entire cell. As the outermost component of the 30 
cell envelope, S-layers play crucial roles in many aspects of cell physiology1. Importantly, 31 
many clinically relevant bacterial pathogens possess a distinct S-layer that forms an initial 32 
interface with the host2, making it a potential target for development of species-specific 33 
antimicrobials. Targeted therapeutics are particularly important for antibiotic resistant 34 
pathogens such as Clostridioides difficile, the most frequent cause of hospital acquired 35 
diarrhea, which relies on disruption of normal microbiota through antibiotic usage3. 36 
Despite the ubiquity of S-layers, only partial structural information from a very limited 37 
number of species is available4-10 and their function and organization remains poorly 38 
understood. 39 
Here we report the first complete atomic level structure and in situ assembly model of an 40 
S-layer from a bacterial pathogen and reveal its role in disease severity. SlpA, the main C. 41 
difficile S-layer protein, assembles through tiling of triangular prisms abutting the cell 42 
wall, interlocked by distinct ridges facing the environment. This forms a tightly packed 43 
array, unlike the more porous S-layer models previously described4,5,8,11. We report that 44 
removing one of the SlpA ridge features dramatically reduces disease severity, despite 45 
being dispensable for overall structure and S-layer assembly. Remarkably, the effect on 46 
disease severity is independent of toxin production and bacterial colonization within the 47 
mouse model of disease.  48 
Our work combines X-ray and electron crystallography to reveal a novel S-layer 49 
organization in atomic detail, highlighting the need for multiple technical approaches to 50 
obtain structural information on these paracrystalline arrays. These data also establish a 51 
direct link between specific structural elements of the S-layer and virulence for the first 52 
4 
time, in a crucial paradigm shift in our understanding of C. difficile disease, currently 53 
largely attributed to the action of potent toxins3. 54 
This work highlights the crucial role of S-layers in pathogenicity and the importance of 55 
detailed structural information for providing new therapeutic avenues, targeting the S-56 
layer. Understanding the interplay between S-layer and other virulence factors will 57 
further enhance our ability to tackle pathogens carrying an S-layer. We anticipate that this 58 
work provides a solid basis for development of new, C. difficile-specific therapeutics, 59 
targeting SlpA structure and S-layer assembly to reduce the healthcare burden of these 60 
infections.  61 
5 
Introduction 62 
The surfaces of most bacteria and archaea are covered with a proteinaceous coat, the 63 
surface or S-layer, that is formed through the self-assembly of individual protein subunits 64 
into a regularly spaced, two-dimensional array2. The tendency of S-layer proteins to 65 
spontaneously form two-dimension (2D) assemblies has hampered structure determination 66 
and restricted understanding of both their function and architecture. Partial S-layer 67 
structures determined from a limited number of species4,5,7,9,10 showcase the huge diversity 68 
in sequence and structure of S-layer proteins and their arrangements, providing some 69 
insights into the mechanisms of anchoring and structural organization. However, no 70 
complete X-ray structure has been presented for any major S-layer protein, despite the 71 
ubiquity of this type of array, particularly among the medically-important Firmicutes such as 72 
Clostridioides difficile. This Gram-positive opportunistic pathogen is the leading cause of 73 
hospital-acquired, antibiotic-associated diarrheal disease globally3.  74 
C. difficile infection (CDI) causes substantial morbidity and mortality with severe disease 75 
characterized by intestinal inflammation, resulting in extensive damage to the colon and 76 
even death3. This pathology has largely been attributed to the direct action of two potent 77 
toxins, that also initiate a proinflammatory response via activation of the inflammasome12. 78 
Other less studied factors, including the S-layer, contribute to the recruitment of 79 
neutrophils, via a TLR/Myd88 dependent signaling pathway13,14. However, the exact role of 80 
the S-layer remains unclear. In C. difficile, the S-layer largely consists of a major S-layer 81 
protein, SlpA (Fig. 1a), responsible for S-layer assembly into a paracrystalline array. Minor 82 
components of the S-layer, belonging to a family of 28 cell wall proteins (CWPs), are 83 
inserted in the array, comprise an estimated 5-10% of the S-layer and provide additional 84 
functions2. Recently, we reported that an S-layer-null mutant of C. difficile was avirulent in 85 
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the acute hamster model of disease, despite apparent normal colonization of the caecum 86 
and colon15. Notably, absence of a functional SlpA resulted in a range of pleiotropic effects, 87 
including reduced toxin production. Although this work suggested a role for S-layer in C. 88 
difficile disease, reduced toxin expression made it impossible to establish a direct effect. 89 
To fully interrogate the role of the S-layer in pathogen survival and host disease severity, we 90 
need a complete, high resolution S-layer structure. Moreover, the uniqueness of each 91 
ゲヮWIｷWゲげ S-layer makes these arrays attractive targets for therapeutic interventions, provided 92 
sufficient structural and functional characterization is available. Here we present the first 93 
complete atomic level model of an S-layer, that of C. difficile, generated by combining high-94 
resolution X-ray crystallography with electron microscopy.  95 
Using this structural information, we uncover elements of SlpA that play an essential role in 96 
C. difficile pathogenicity. We demonstrate that an intact wild type S-layer is an absolute 97 
requirement for full disease severity, in a mechanism unrelated to toxin production or host 98 
colonization. 99 
 100 
C. difficile major S-layer component forms an intricate complex 101 
In order to address the knowledge gap on the C. difficile S-layer, we first sought to 102 
determine the structure of its main component, SlpA, which is post-translationally cleaved 103 
into two S-layer proteins (SLPs); the high molecular weight (HMW) and low molecular 104 
weight (LMW)16, herein referred to as SLPH and SLPL, respectively. These subunits then form 105 
a complex (referred to as H/L) that is incorporated in the S-layer (Fig. 1a). The structure of 106 
the full-length H/L complex was determined by X-ray crystallography to an overall resolution 107 
of 2.55 Å (PDB ID: 7ACY) by combining single anomalous dispersion sulphur data (S-SAD) and 108 
molecular replacement using substructures of the interacting domains (LMW SLP interacting 109 
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domain, LID, and HMW SLP interacting domain, HID; PDB ID: 7ACW) and SLPL/HID (PDB ID: 110 
7ACV) (Fig. 1). Our H/L structural model reveals three distinct regions: the pseudo-threefold 111 
SLPH tile, an intricate LID/HID interacting motif and a third region composed of two 112 
domains, D1 and D2, of SLPL (Fig. 1b). These regions define two separate planes, with the 113 
SLPL spanning ~35 Å above the SLPH plane (Fig. 1b), linked by the LID/HID motif. 114 
 SLPH is composed of the three conserved cell wall binding motifs - CWB2 - that define the C. 115 
difficile cell wall protein (CWP) family2, and the HID. The three CWB2 motifs form a 116 
triangular prism and adopt an intertwined fold, with a é-strand from one CWB2 inserting 117 
into the neighbouring domain to complete a é-sheet, sandwiched between two ü-helical 118 
regions (Extended Data Fig. 1a).  At the core of the tile sits a helical bundle with each 119 
individual CWB2 contributing one ü-helix, while two ü-helices define the vertices of the 120 
pseudo-threefold arrangement (Extended Data Fig. 1a).   121 
The HID motif interlocks with LID in an intricate arrangement, reminiscent of a paperclip; 2 122 
ü-helices from LID and one from HID pack against a é-sheet formed by insertion of one HID 123 
between two LID é-strands (Fig. 1c, Extended Data Fig. 2b, PDB ID: 7ACW). This novel 124 
structural motif locks SLPL and SLPH in a tight heterodimer, providing a structural basis for 125 
the stability of the H/L complex6. 126 
 127 
In order to identify residues essential for interaction of the two subunits, we analyzed H/L 128 
complex formation in an ELISA-based assay with a panel of individual point mutants (Fig. 1d, 129 
comprehensive list of tested mutants in Extended Data Fig. 2, see Methods for details). 130 
Mutations of a single amino acid within LID (F274A) or HID (Y27A) were sufficient to 131 
destabilize the H/L complex. Moreover, expression of either point mutant in an SlpA-null 132 
background resulted in SLPL shedding from the cell surface of C. difficile and detection of a 133 
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fraction of SLPH in the culture supernatant. Loss of SLPL also resulted in partial degradation 134 
of SLPH (Fig. 1e); N-terminal sequencing revealed truncation of the HID, indicating that this 135 
region is unstable in the absence of the LID/HID interaction (Fig. 1e). 136 
 137 
Our structural model shows that SLPL protrudes from the interacting motif, with D1 closest 138 
to the SLPH plane and D2 extending outwards at an angle of ~120°, away from the long axis 139 
of D1. Whilst D1 is well ordered, formed by a 5-strand é-sheet packed against two ü-helices, 140 
D2 is predominantly composed of long, flexible loops, particularly at the externally-exposed 141 
face (Fig. 1b); it is characterized by high B-factors (Extended data Fig. 1b) and weaker 142 
electron density. Structural flexibility accommodates high sequence variability observed 143 
across different strains of C. difficile, with 13 SlpA cassette types (SLCTs) currently 144 
identified17. Residues with high B-factor map almost identically to sequence variation 145 
hotspots in D2 (Extended Data Fig. 1b, 1c). 146 
Conformational flexibility in the organization of SlpA is further demonstrated by different 147 
arrangements observed in the structure of a truncated derivative of SlpA (SLPL/HID) and the 148 
H/L complex. In the structure of the truncated SLPL/HID complex (PDB ID: 7ACV), the D1-D2 149 
domains exhibit an orientation relative to the interacting domains different from that seen 150 
in the corresponding H/L complex (R7404 strain, SLCT-7b, PDB ID: 7ACX) (Extended Data Fig. 151 
2a). Our models indicate the presence of a hinge, formed by the D1-LID linker (Extended 152 
Data Fig. 2a, SI). Analysis of interdomain dynamics also reveals increased mobility within D2. 153 
The fact that we observed this conformational flexibility in our crystal models, with no 154 
apparent effect on the fold of individual regions, suggests how the effector domains of 155 
other CWPs inserted in the functional S-layer can be accommodated by flexible 156 
rearrangement of D2 (see SI discussion).  157 
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 158 
Crystal lattice reflects in situ S-layer assembly 159 
Due to the natural tendency of SlpA to form 2D crystal arrays, we hypothesized that the 160 
packing of our crystal structures might reflect the in situ S-layer arrangement. Two H/L 161 
complexes, related by pseudo-twofold symmetry, are present in the P1 asymmetric unit, 162 
packed in a 2D planar array. The 2D lattices are then stacked to extend the crystal into the 163 
third dimension (Extended Data Fig. 3a). The 2D lattice is achieved by tiling of SLPH, with 164 
interlocked ridges of SLPL molecules covering gaps between the tiles, creating a tightly 165 
packed layer (Fig. 2). Lattice contacts between CWB2 motifs of neighbouring SLPH molecules 166 
involve helix-helix interactions between the symmetry-related copies of helix 12 (see 167 
topology in Extended Data Fig. 1), as well as electrostatic interactions generating a tightly 168 
bonded network (Fig. 2a and Extended Data Fig. 4). The charge distribution generated by 169 
the trimeric arrangement of the CWB2s provides complementary charges across the lateral 170 
faces of the SLPH triangular prism tile (Extended Data Fig. 3b and 5a), allowing these 171 
interactions to be established (Extended Data Fig. 4). The pseudo-threefold organization of 172 
the CWB2s that define the CWP family is also seen in other minor constituents of the S-layer 173 
whose structures have been determined18. Analysis of the charge distribution in Cwp6 and 174 
Cwp8 CWB2s (Extended Data Fig. 5) indicates that charge complementarity could play a role 175 
in interaction between lateral faces of CWB2s triangular prisms from different CWPs and 176 
SLPH within a mature S-layer. The environment- and cell-facing sides of SLPH exhibit 177 
considerable charge differences, with a mostly negatively charged external surface and a 178 
largely non-polar cell wall-facing base, decorated by positive patches (Extended Data Fig. 179 
5a). The positive patches at the cell-wall base could provide the mechanism for anchoring 180 
10 
SlpA to the cell wall via interactions with the anionic secondary cell wall polymer PSII19. 181 
 182 
Other S-layer proteins have been proposed to create relatively permeable arrays8,11, with 183 
pores ranging from ~30 to up to 80 Å and possibly wider5,10,20. In contrast, tiling of SLPH and 184 
the SLPL ridges generates a compact lattice apart from two distinct pores in the C. difficile S-185 
layer array. Pore 1 (Fig. 3b, between molecules 1 and 3) is approximately 20 Å across the 186 
widest point at the environment-facing surface and is partially occluded by the LID/HID 187 
motif narrowing it down to an 11 Å wide cavity. The interlocked D2 domains of adjacent 188 
SLPL molecules cap this pore, further reducing access from the external environment to the 189 
cell wall (Fig. 3b, molecules 1 and 3, and Extended Data Fig. 3c). The second pore, formed 190 
between two SLPH (Fig. 3b, molecules 1 and 2) is fully accessible at both faces of the layer 191 
and has a width of approximately 11 Å (pore 2, Fig. 2b), but is narrowed to 8 Å by two 192 
pseudo-symmetry equivalent arginine residues within 10 Å of the pore outward side 193 
(Extended data Fig. 3c).  194 
 195 
We next investigated if the planar crystal packing observed in the X-ray structure reflects 196 
the in situ packing of the native S-layer assembly. Intact S-layer extracted from C. difficile 197 
vegetative cells (native S-layer ghosts) formed collapsed capsules. These double-layered 2D 198 
crystals were interrogated by electron crystallography, with rotationally separated 199 
diffraction patterns observed from images of the superimposed layers (Fig. 2c). As we had 200 
hypothesized, the p2 symmetric 2D lattices of native S-layer ghosts (a = b = 85 Å, á = 100°) 201 
were consistent with unit cell parameters of the stacked lattices in the 2D plane of the X-ray 202 
crystals (b = 78 Å, c = 80 Å, ü = 100°), pointing towards a similar packing arrangement (Fig. 203 
2c, Extended Data Fig. 6a). The 3D reconstruction from images of the native ghosts revealed 204 
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a molecular envelope with a staggered ridged surface on one face of the S-layer, with deep 205 
grooves between the parallel ridges, and an opposing surface defined by paired, globular 206 
domains arranged in rows (Fig. 2d). These features recapitulate the surface characteristics 207 
of the H/L array in the X-ray crystal structure, with the ridge-like arrangement of the SLPL 208 
above the SLPH globular rows. Indeed, manual fitting of the 2D X-ray lattice as a single rigid 209 
body into the EM density matches the ridged surface to SLPL, with the paired globular 210 
domains on the opposite face corresponding to the SLPH CWB2 motifs (Fig. 2d). The ridges 211 
are also observed in cryo-electron microscopy (cryo-EM) side views of intact cells (Fig. 2c). 212 
This confirms that the X-ray crystal lattice of the H/L complex has the same overall 213 
arrangement as the in situ lattice of a mature S-layer in intact cells, therefore establishing 214 
our crystallographic model as a template for interrogating S-layer assembly in C. difficile. To 215 
our knowledge, this is the first time that X-ray structural models of a full-length S-layer 216 
protein reflect the observed S-layer assembly in situ. 217 
 218 
Probing the S-layer assembly model 219 
In order to further test our S-layer assembly model, we sought to generate an altered, yet 220 
functional S-layer. The observed interactions for assembly involve mainly the SLPH tiles and 221 
D1 in SLPL. Moreover, these regions are conserved across different SLCTs (Extended data Fig. 222 
4 and SI). We therefore hypothesized that the structurally flexible and less conserved D2 223 
domain (Extended data Fig. 1b, 1c) might be dispensable for maintaining S-layer assembly 224 
and engineered a mutant strain devoid of D2 - RらDヲ (producing SlpARらDヲ; see Methods). The 225 
X-ray crystal structure of the H/L complex from SlpARらDヲ (Fig. 3c and Extended Data Fig. 7, 226 
PDB ID: 7ACZ) superimposes readily onto the full-length model (backbone RMSD 1.09 Å), 227 
with the absence of D2 not perturbing the overall protein fold. Moreover, the crystal lattice 228 
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is similar to wild type, with equivalent interactions between SLPH tiles and D1 domains 229 
(Extended Data Fig. 7). Importantly, the absence of D2 exposes pore 1 between SLPH tiles 230 
(Fig. 3d and Extended Data Fig. 7c), which is occluded by interlocking D2 domains in the full-231 
length structure. This creates two openings in the array of about 16 Å, with potential 232 
functional implications as it could indicate a more permeable S-layer than in the wild type 233 
structure, with twice as many pores, of slightly increased size.  234 
Analysis of native S-layer ghosts from bacteria producing the SlpARらDヲ revealed that, despite 235 
lacking nearly half of SLPL (145 of 318 amino acids), an S-layer with identical lattice 236 
parameters to the wild type is still formed. The calculated molecular envelope retains the 237 
paired globular domain organization (Fig. 3a) but the opposing face lacks the staggered 238 
ridge feature seen in the wild type EM reconstruction (Fig. 3a), confirming our assignment of 239 
this missing density to the D2 domain. This is further validated by difference maps of cryo-240 
EM projections for full-length SlpAR20291 and SlpARらDヲ showing a region of significant 241 
difference density matching the position of D2 in the complete structure (Extended Data Fig. 242 
6). 243 
Together, the structural models of SlpARらDヲ and the corresponding S-layer reconstruction 244 
confirm our model for S-layer assembly, where SLPH tiling and SLPL D1 domains provide the 245 
key contacts for paracrystalline array formation.   246 
 247 
An altered S-layer surface reduces C. difficile virulence 248 
The retention of S-layer integrity, despite loss of an exposed structural domain, provided an 249 
unprecedented opportunity to directly assess the role of SlpA in C. difficile infection. We 250 
employed the mouse model of acute disease, which allows a nuanced analysis of 251 
colonization and pathology, typified by weight loss and caecal and colon inflammation21. 252 
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Animals infected with the wild type strain R20291 (producing SlpAWT) lost on average 8% of 253 
their body weight within 24 h of infection and 12% by the peak of infection at 48 h, before 254 
returning to pre-infection weights approximately 4 days after infection. In contrast, 255 
infection with RらDヲ (producing SlpARらDヲ) resulted in little apparent disease; animals 256 
displayed only a 1% weight loss after 24 h and 5% after 48 h, before a gradual return to pre-257 
infection weight (Fig. 4a). As RらDヲ was derived from our previously characterized slpA 258 
mutant FM2.515, a control for any potential background genetic variation was needed. A 259 
previously characterized strain FM2.5RW15  contains a watermarked copy of the wild type 260 
slpA gene (encoding SlpARW) and RらDヲ was constructed in a similar way but contains a 261 
truncated version of slpA (see Methods for details). Animals infected with FM2.5RW strain 262 
showed similar patterns of disease as those infected with wild type. 263 
To determine if the surprising loss of virulence seen for RらDヲ could be attributed to 264 
impaired colonization, we quantified C. difficile present in faeces collected each day post-265 
infection (Fig. 4b) and in intestinal contents post-mortem (Extended Data Fig. 8). No 266 
statistically significant differences in bacterial recovery were observed, demonstrating that, 267 
although D2 is surface-exposed in the S-layer, it is not required for efficient colonization. 268 
RらDヲ sporulated normally in vitro (Extended Data Fig. 9a), but displayed an increased 269 
sensitivity to lysozyme in comparison to the wild type strain R20291 (Extended Data Fig. 9b).  270 
As the perceived dogma is that the intestinal pathology and symptoms associated with CDI 271 
are largely toxin-driven, we next examined toxin expression and activity in vitro (Extended 272 
Data Fig. 9c, 9d) and in intestinal contents (Fig. 4c and Extended Data Fig. 8f). Surprisingly, 273 
no toxin production defect was observed, suggesting the decrease in disease severity seen 274 
with RらDヲ is a direct consequence of the loss of the surface-exposed D2 domain. Strikingly, 275 
although toxin activity was equivalent in all strains, a reduced level of epithelial damage was 276 
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observed in tissue from RらD2-infected mice. Indeed, assessment of other markers including 277 
the extent of inflammatory infiltrate, tissue edema and crypt length measurements 278 
indicated that damage was reduced in RらDヲ infected mice when compared with animals 279 
infected with WT or control strain at the acute point of infection (48 h post-infection; Fig. 4d 280 
and Extended Data Fig. 8c).  281 
Together, these observations demonstrate that the S-layer contributes directly to C. difficile 282 
disease severity, in a toxin-independent manner. Importantly, our data also reveal that the 283 
most surface-exposed domain of SlpA is dispensable for effective colonization, suggesting 284 
that other regions of the protein or other CWPs are likely to be involved in direct host-285 
pathogen interactions required for colonization. 286 
 287 
Discussion 288 
Here we report the first experimentally determined structure of a complete S-layer protein 289 
from a medically important human pathogen, which allows us to observe the organization 290 
of the paracrystalline array at an atomic level. The tight packing of H/L complexes in the 291 
crystal replicates assembly into the functional S-layer which we observe in situ by electron 292 
microscopy. The repeating crystallographic array is created by tiling of one of the subunits 293 
(SLPH), which also anchors the S-layer to the cell wall. Most other S-layers characterized to 294 
date are composed of distinct domains that contribute either to lattice formation 295 
(crystallization domain) or cell surface attachment (anchoring domain)2. In the C. difficile S-296 
layer, the crystallization and anchoring functions are combined in the SLPH, with assembly 297 
relying on contacts between adjacent tiles. Moreover, contacts between SLPL and 298 
neighbouring H/L complexes further expand the S-layer assembly network. The SLPL ridges 299 
are also important for generating a structure impermeable to the majority of folded 300 
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proteins such as lysozyme and other large molecules as it covers the pores present within 301 
the packing of the triangular prism SLPH tiles. This tight packing raises the question of how 302 
large molecules such as the C. difficile toxins22 are exported to the environment. 303 
Furthermore, S-layers must be able to accommodate cell growth and division and this array 304 
needs to adapt to the curvature of the cell poles. Having tightly packed core subunits or 305 
domains, maintained by interchangeable electrostatic interactions, that are then decorated 306 
with more flexible regions is a simple, yet seemingly effective, way to achieve both 307 
requirements. Points of mismatched symmetry as observed by tomography (Extended Data 308 
Fig. 10) could provide increased flexibility and permeability, creating discrete points for 309 
export of larger molecules (see SI Discussion). Incorporation of other CWPs within the 310 
crystalline array involves interactions of the conserved CWB2 domains that define C. difficile 311 
cell wall proteins2, while the flexibility of the D2 domain allows packing of other effector 312 
CWP motifs present in the minor constituents of the S-layer (see SI discussion).  313 
Our investigation of the functional role of the S-layer revealed that toxins are necessary but 314 
not sufficient for full disease severity, a paradigm shift in our understanding of C. difficile 315 
infections. Despite being dispensable for protein fold or even S-layer assembly, D2 seems to 316 
confer a functional role to SLPL and its absence leads to reduced disease severity. 317 
Surprisingly, this is not due to changes in colonization of the gut, suggesting other domains 318 
or S-layer proteins are involved in this type of interaction with the host. Instead, the 319 
presence of D2 is associated with increased levels of inflammation when compared to the 320 
full-length protein (Fig. 4). In C. difficile infections, tissue inflammation has been associated 321 
with activation of additional immune pathways that results in enhanced disease23. The high 322 
sequence variability and structural flexibility of the D2 domain, in contrast to the conserved 323 
and relatively rigid SLPH, could therefore confer an immune-evasion mechanism as a result 324 
16 
of the evolutionary pressure of the dynamic environment of the gut. It is therefore tempting 325 
to speculate that D2 is directly involved in the activation of the host immune response, 326 
however, the molecular mechanisms involved remain to be elucidated (see SI discussion).  327 
Importantly, we have established a direct link between the S-layer and disease severity and 328 
our characterization of S-layer assembly in C. difficile reveals new potential therapeutic 329 
avenues. The interacting SLPH subunits and the flexible D2 domains present key targets for 330 
disruption of the S-layer, and molecules that affect S-layer assembly are attractive 331 
therapeutic agents. 332 
  333 
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Fig. 1: Architecture and key interactions in C. difficile SLPH/SLPL (H/L) complex  
a, SlpA arrangement on the cell surface (left; SLPL colored in gold and SLPH in slate blue) with 
detailed organization of protein building blocks in its primary sequence (middle) and 
quaternary structure (right). Numbering based on the subunits of SlpA from strain CD630, S-
layer cassette type 7 (SCLT-7), PBD ID: 7ACY. 
b, Cartoon representation of H/L complex as viewed from the external environment (top 
view, left) and side (right). The SLPL protrudes above the SLPH subunit, creating a two-plane 
arrangement. Three distinct structural features are observed: SLPH, D1 and D2, and LID/HID 
(regions highlighted in gray). 
c, ‘Paperclip’ organization of the interacting domains LID/HID is maintained by a range of 
interactions, with selected interface residues identified in strain R7404 (SCLT-7b, PDB ID: 
7ACW) depicted as sticks.  2mFo-DFc electron density map is shown on the interacting 
amino acid pairs as a grey mesh contoured at 1.5 s. Specific interatomic interactions 
identified with PDBePISA are represented as a dashed line (more details on Extended Data 
Fig. 2). 
d, Probing of CD630 H/L complex interactions in vitro with ELISA, comparing effects of intact 
SLPL (gold circles), SLPH (slate blue circles), variants lacking interacting domains (black 
squares) and substitution mutants of F274A (structurally equivalent to F270 in R7404 
LID/HID depicted in c, dark green triangles) and Y27A (light green triangles) on H/L complex 
formation. Graphs represent mean ± standard deviation (SD) of n = 3 experiments, with 
least squares curve fit of product formed upon interaction of the two subunits.  
e, Western blot of cell surface extracts and culture supernatants, detecting (black 
arrowhead) SLPH (left) and SLPL (right) in strains devoid of endogenous slpA and expressing 
plasmid-borne SlpACD630 native protein or variants with either F274AL or Y27AH substitution 
mutants in SLPL or SLPH (denoted in subscript), respectively. Detected product of partial 
degradation of HMW indicated with an asterisk. 
  
 
 
Fig. 2: Planar crystal packing in the X-ray structure fits the in situ packing of the native S-
layer 
a, 2D schematic of H/L complex crystal packing, indicating the interaction network linking a 
single SLPL (gold)/ SLPH (slate blue) complex with six other molecules in a planar 
arrangement generated by SLPH tiling. Array is depicted as seen from the extracellular 
environment, with symbols representing key interaction types in the crystal lattice, shown 
in detail in Extended Data Fig. 4. 
b, Cartoon representation of the H/L planar array (PDB ID 7ACY, colored as in a, views as 
defined in Fig. 1b). 
c, Native C. difficile S-layer ghosts (electron micrograph, negatively stained, left. Scale bar: 2 
µm) were used to compute Fourier transforms (middle). Typically spots from two or more 
lattices were observed. Reciprocal lattice axes (red and white axes) are indicated for two 
observed lattices !scale bar 0.0125 Å-1). Intact frozen hydrated C. difficile cells, examined by 
cryo-electron microscopy (right), show distinctive ridged surface indicated by red arrows 
(scale bar 50 nm). 
d, Orthogonal views of the 3D reconstruction of negatively stained S-layer ghost indicating 
the overall envelope in the native lattice. A rigid body fit of the structure of H/L complex 
determined by X-ray crystallography (PDB ID: 7ACY, cartoon representation, SLPL - gold, SLPH 
- slate) indicates a similar arrangement in the native S-layer ghosts and crystal packing. 
Reconstruction is shown from the environment (top left) and cell wall (top right), and side 
views in the 2D plane (bottom panels). 
  
 
 
Fig. 3: The flexible D2 domain is dispensable for S-layer assembly 
a, Superimposition of the 3D reconstruction of negatively stained S-layer ghost containing 
SlpA devoid of domain D2 (SlpARΔD2, light blue solid surface) on the reconstruction of native 
wild type S-layer ghost (SlpAR20291, grey mesh). The missing density can be largely ascribed to 
that of the missing D2 domain (indicated with black arrowheads). Views are as described in 
Fig. 2d. 
b, Fit of the SlpARΔD2 structure determined by X-ray crystallography (colored as in c) into the 
S-layer (gray) reconstruction indicates a similar arrangement in the crystal packing and the 
native array. Views as in a.  
c, Cartoon representation of the SlpARΔD2 H/L complex crystal structure (slate blue and gold, 
PDB ID: 7ACZ), superimposed onto SlpACD630 H/L complex structure (PDB ID: 7ACY, gray). 
Deleted D2 region is marked with a dashed line on the CD630 structure and corresponding 
schematic representation of the complex. Views as in Fig. 1b. 
d, Surface representation of wild type H/L (7ACY, left) and SlpARΔD2 H/L(7ACZ, right) crystal 
packing showing pores in the 3D crystal lattice (top). Positions of pores marked with 
arrowheads (pore 1 in magenta, pore 2 in cyan) are equivalent in both lattices.  
Fig. 4:  In vivo evaluation of C. difficile 
strains producing a modified S-layer 
a, Relative percentage weight loss of 
antibiotic-treated animals infected 
with R20291 (SlpAWT, black triangle), 
RΔD2 (SlpARΔD2, blue triangle), 
FM2.5RW (SlpARW, orange triangle) 
and antibiotic-treated uninfected 
animals (Uninfected, yellow triangle). 
b, Total C. difficile counts (CFU ml-1) 
recovered from faeces at 24, 48 and 
72h post infection.  
c, Measurement of toxin activity in 
filtered caecal extracts from individual 
animals. Annotations as in a.  
d, Hematoxylin and eosin stained 
caecal histological sections from 
animals 48 h post infection with C. 
difficile, representing acute disease. 
Arrowheads highlight the margination 
and tissue infiltration of 
polymorphonuclear cells (PMNs) and 
the breached epithelial barrier 
(indicated with asterisk). The extent of 
tissue edema between basal membrane and musculature is highlighted (line). Crypt 
hyperplasia is discernible in tissue from R20291 (SlpAWT) and FM2.5RW (SlpARW) infected 
animals, compared to antibiotic-treated uninfected animals or those infected with RDD2 
(SlpARΔD2).  
Data analysis represents a total of up to 15 mice per strain tested from 3 experiments 
expressed as mean (± SEM) a (10-15 mice), c (5 mice); or as violin plots showing medians 
(solid lines), upper and lower quartile (dashed line) and max/min range (top and base of the 
plot) b, (min 5 mice). Non-parametric, non-paired Mann-Whitney statistical tests were 
performed with differences of *p = <0.05, ****p = <0.0001 indicated (a, c). Scale bars of 
100mm are shown (d). 
 
 
 
Extended Data Fig. 1: H/L complex organization and conservation 
a, Topology of the mature SlpACD630 H/L complex, retrieved from structure analysis with 
PBDsum and Coot. SLPL represented in gold and SLPH colored in blue. Color shading 
represents different domains/motifs. Numbering of secondary structure components based 
on PDB ID 7ACY, subscripts indicate the relevant subunit. 
b, Putty representations of SlpACD630 H/L complex showing B-factors ranging from low (blue 
and narrow) to high (red and wide). High B-factors are indicative of disorder/flexible 
regions. 
c, Conservation of the SlpA sequence across annotated SlpA Cassette Types (SLCTs) depicted 
on putty representations of SlpACD630 H/L complex, colored from conserved (purple) to 
variable (cyan). Conservation was calculated using Consurf web server (see Methods for 
details). 
  
 
Extended Data Fig. 2: Interdomain interfaces of H/L complex 
a, Superimposing structures of SLPL/HID (gold/slate blue, PDB ID: 7ACV) onto the native 
complex of SlpAR7404 (SLCT-7b, PDB ID: 7ACX) (blue/white) reveals flexibility of the LID-D1 
linker, as illustrated by rotation of D1-D2 domains in relation to fixed position of LID/HID 
motif (left). The hinge loop enabling this conformational flexibility (determined by 
DynDom6D) is colored in red. The backbone displacement (colored from blue – low, to red – 
high Ca displacement deviation) is shown on the alignment of D1-D2 region of both 
structures (middle; SLPL/HID – opaque, H/L – semi-transparent) with the rotation angle of 
the LID/HID motif indicated with an arrow. Structural dynamics (right) of the SLPL/HID 
represented as increasing mobility (colored blue – rigid, to red - mobile) calculated based on 
elastic network models implemented in DynOmics ENM version 1.0 server. 
b, Key interactions identified at the interface of the LID/HID complex from strain R7404 
(SLCT-7b) (left; identified with PDBePISA in PDB ID: 7ACW) informed site directed 
mutagenesis for functional assessment by ELISA. Effects of point substitution mutations in 
SLPL (middle) or SLPH (right) on complex formation were tested. Graphs represent mean ± 
SD of n = 3 experiments, with least squares curve fit. 
 
  
 
Extended Data Fig. 3: SLPH tiling and SLPL interactions create a tightly packed array 
a, 3D crystal packing of SlpA showing the planar layer of a H/L array in slate blue and gold 
cartoon representation stacked between symmetry-related layers represented as white 
surface. 
b, Tiling of SLPH CWB2 motifs via charge complementarity across each triangular prism face. 
Poisson-Boltzmann electrostatic potential calculated for SlpACD630 SLPH, represented as a 
charge distribution (positive in blue and negative in red, as per electronegativity gradient 
key) on the surface representation of SLPH array, as defined in Fig. 2. Interacting surfaces 
between molecules 1-2, defined by pseudo-symmetry related CWB23-CWB21, and between 
molecules 1-3, defined symmetry-related CWB23 triangular prism faces, are labelled. Cavity 
between symmetry-related CWB21-CWB22 surfaces, represented by green arrows (left) is 
partially obstructed by HID domains (electrostatic potential surface representation, right) 
and completely occluded by SLPL (gold) as shown on the right panel. A long cavity of ~70 Å 
at the CWB22 vertices represented by purple arrow (left) is also occluded by HID domains 
and interacting SLPL molecules (right). 
c, Zoomed in view of the pores generated by SlpACD630 multimerization. Pore 1, uncovered 
top view, as defined in Fig. 1 (top), top view covered by D2 (middle, gold). Pore 2 – top view 
(bottom). Widest openings are labelled for each pore. 
d, Cross section views of pore 1 (top, uncovered by removing domain D2 from structural 
model; middle, covered by D2 in crystal structure, gold) and pore 2 (bottom). Neighbouring 
SLPH (slate blue) and SLPL (gold) molecules that create the pores are shown in surface 
representation.  
e, Hydrophobicity characteristics of the residues lining pore 1 (top) and 2 (bottom) 
calculated in ChexVis (see Methods for details) according to Kyte-Doolittle scale, ranging 
from hydrophilic (green) to hydrophobic (blue), as per hydrophobicity gradient key (middle). 
f, Poisson-Boltzmann electrostatic potential calculated for residues lining pore 1 (top) and 2 
(bottom) represented as a charge distribution (positive in blue and negative in red, as per 
electronegativity gradient key). Views are as in d, (left) and as a slice across the largest pore 
surface (right). Pseudo-symmetry related lysine residues at the top and arginine residues at 
the bottleneck of pore 2 are highlighted. 
  
 
Extended Data Fig. 4: Interactions between neighbouring molecules in S-layer packing 
a, Details of the interaction network between 7 SlpACD630 H/L complexes within the 2D array, 
with each molecule represented as cartoon, interacting residues as sticks (colored as in 
schematic for molecule 1, white for neighbouring residues, with molecule number identifier 
in parenthesis) and interactions as dashed lines. The interface depicted in each panel is 
marked by a corresponding box within the array representation. Interaction types are 
shown as bars (salt bridges), circles (hydrogen bonds) and diamonds (between D2 domains) 
in the central schematic. 
b, Clustermap of predicted conservation across known SLCTs for sidechain-sidechain 
interactions found in SlpACD630 H/L. Representatives of each SLCT were aligned (SI data), 
SWISS-MODEL structural homology models were generated and superimposed. The 
residues corresponding to interactions identified in SlpACD630 H/L were analyzed and 
interaction conservation compared to SLCT-7 is depicted based on residue conservation and 
prediction of similar or different type of possible interaction. Key: 0 – no residue 
conservation, unstructured region; 1 – one conserved residue, unstructured region; 2 – no 
residue conservation, no interaction; 3 – one conserved residue, no predicted interaction; 4 
– no residue conservation, different interaction type; 5 – one conserved residue, different 
interaction type; 6 – no residue conservation, same interaction type; 7 – one conserved 
residue, same interaction type; 8 – residues and interaction conserved. 
  
 
Extended Data Fig. 5: Charge distribution across CWB2 motifs in SLPH and two minor 
components of the C. difficile S-layer  
Comparison of the Poisson-Boltzmann electrostatic potential calculated for CWB2 motifs 
from SlpACD630 (a), Cwp6 (b) and Cwp8 (c). The triangular CWB2 motifs of each CWP were 
superimposed onto the SlpACD630 CWB2s to determine orientation of Cwp6 and Cwp8. Views 
are shown from the extracellular and cell wall surfaces, followed by side views of the lateral 
faces defined by two interacting CWB2s, as per SlpACD630 H/L complex orientation at the cell 
surface. 
  
 
Extended Data Fig. 6: Cryo-electron microscopy of wild type and SlpARΔD2 S-layer ghosts.  
a, Projection map of frozen hydrated native S-layer ghost from strain R20291 at 8.7 Å 
resolution. Contours represent density greater than mean density, contour interval 0.5 RMS 
density, as per gradient.  
b, Superimposition of the reconstruction of negatively stained native S-layer (gray surface) 
on the projection in a.  
c, Projection map at 8.7 Å resolution of frozen hydrated C. difficile S-layer ghost containing 
SlpARΔD2, depicted as in a.  
d, Wild type minus SlpARΔD2 difference projection map. Positive difference density is seen to 
correspond with the projection of the ridge-like density in the 3D reconstruction depicted in 
b.  
e, Superposition of isolated domain D2 crystal structure (gold surface) on the difference 
projection map in d. Pseudo-symmetrically related structures are shown together in the 
central density. 
  
 
Extended Data Fig. 7: Absence of D2 generates a more porous H/L packing 
a, 2D tiling representation of SlpARΔD2 assembly in crystal packing (PDB ID: 7ACZ), with 
identified interactions represented as symbols defined in the key (as in Fig. 2). 
b, Cartoon representation of the SlpARΔD2 array (SLPL colored in gold and SLPH in slate blue) 
in top and a side view (as defined in Fig. 2). 
c, Zoomed in view of the pores generated by SlpARΔD2 multimerization. From top to bottom: 
pore 1 – top view and cross-section, pore 2 – top view and cross-section. Widest points are 
marked in each view (black arrows).  
 
 
Extended Data Fig. 8: In vivo phenotypic characterization of RΔD2 
a, and b, Total C. difficile CFUs recovered from the lumen (a) and tissue (b) of dissected 
caeca of animals euthanized 48 and 96 h post-infection.  
c, Quantification of histological sections harvested 48 h post-infection. Three independent 
sections from two animals from each infection group were single blind scored on four 
independent criteria (epithelial damage, neutrophil margination and tissue infiltration, 
haemorrhagic congestion and tissue edema, crypt hyperplasia). Scores were assigned for 
each feature ranging from 1 for no change to 4 indicating substantial change, and 
cumulative scores calculated. 
d, and e, Total C. difficile CFUs in the lumen (d) and tissue (e) from dissected colons of 
animals euthanized 48 and 96 h post-infection.  
f, Toxin B activity in filtered luminal contents of the colon. Monolayers of Vero cells were 
incubated with serial dilutions of filtered luminal contents from individual animals. Toxicity 
is represented as the maximum fold dilution at which toxicity was observed using samples 
from animals during the acute phase of infection (48 h) and during recovery (96 h).  
Data analysis represents a total of 10 mice per strain from 2 independent experiments as 
violin plots showing medians (solid lines), upper and lower quartile (dashed line) and 
max/min range (top and base of the plot) for panels a-b, d-e (min 5 mice per group), 
calculated means (± SEM) from histology scoring (2 mice/ 3 sections) in panel c or mean 
toxin activity (±SEM, min 5 mice per group tested in duplicate) for panel f. Non-parametric, 
non-paired Mann-Whitney statistical tests were performed with differences of *p = <0.05, 
** p=<0.005 indicated (e, f).  
  
 
Extended Data Fig. 9: In vitro phenotypic characterization of RΔD2 
a, Sporulation. Stationary phase cultures were incubated for 5 days anaerobically at 37°C. 
Total CFUs were enumerated on BHI-S agar supplemented with taurocholate (0.1% v/v), 
while spores were enumerated on the same solid medium following incubation at 65°C for 
30 min to kill vegetative cells. b, Lysozyme resistance. Cultures were inoculated at an 
OD600nm of 0.05 and grown anaerobically at 37°C with hourly OD600nm measurements. Where 
indicated, lysozyme (500 µg ml-1) was added after 2.5 h growth. c, Toxin B activity in vitro. C. 
difficile strains were grown for the indicated time in TY broth. Monolayers of Vero cells were 
incubated with serial dilutions of culture supernatants. Toxicity was determined by 
observation of the integrity of the monolayers through Giemsa staining. d, Detection of 
Toxin B in culture supernatant by western immunoblot. C. difficile strains were grown in TY 
broth for 48 h and secreted toxin B was detected using a monoclonal antibody following 
SDS-PAGE and electrotransfer to PVDF membrane. Data are presented as mean values (± 
SD) from 3 biological replicates, assayed in duplicate (a-b) or the mean maximum dilution (± 
SEM) at which toxicity was observed from six independent experiments (c). 
 
  
 
Extended Data Fig. 10: Patches of S-layer present in cryo-electron tomographic slice of 
extracted S-layer ghosts 
a, Distinct S-layer lattice patches can be seen in tomographic slices of S-layer ghosts, with 
‘fault lines’ present where patches intersect (white arrows).  
b, Annotated patches (dotted lines) have distinct orientations on the surface, with unit cell 
axes of the different lattices highlighted (black arrows). Scale bar: 25nm. 
1 
Methods 1 
Strains and growth conditions 2 
C. difficile and E. coli strains are described in Table 1. E. coli strains were routinely grown at 3 
37 °C in LB broth and on LB agar (VWR or Fisher Scientific). C. difficile strains were routinely 4 
grown under anaerobic conditions at 37 °C on BHI (Oxoid) or BHI-S1 agar and in TY broth2. 5 
Growth media were supplemented with chloramphenicol (15 μg ml-1), thiamphenicol (15 μg 6 
ml-1) or kanamycin (50 μg ml-1) as required. For detection of C. difficile in mouse faeces and 7 
tissues, samples were cultured on Brazier’s agar supplemented with 5% (v/v) egg yolk 8 
(LABM, Neogen), 10% (v/v) defibrinated horse blood (TCS Biosciences) and 9 
cycloserine/cefoxitin (LABM, Neogen). For detection of RΔD2, samples were additionally 10 
plated on ChromID® C. difficile (Biomerieux) chromogenic agar plates.   11 
 12 
Construction of RΔD2 13 
DNA oligonucleotides are described in Table 2. Plasmid pRPF233, containing a copy of the 14 
complete slpA gene from C. difficile strain R20291 was modified by inverse PCR using 15 
oligonucleotides RF102 and RF103 to delete the coding sequence of SlpA residues 115-259 16 
and replace with GGAGGT, encoding two glycine residues. The resulting plasmid, pOB001, 17 
was transferred to the C. difficile S-layer mutant strain FM2.53 by conjugation4. FM2.5 18 
displays an aberrant colony morphology that is easily distinguished from wild type C. 19 
difficile. Recombination between the plasmid-borne slpA gene and the mutated copy on the 20 
chromosome was detected by reversion to normal colony morphology. Plasmid curing was 21 
confirmed by loss of thiamphenicol resistance, the chromosomal location of the engineered 22 
slpA gene was confirmed by PCR and the resulting protein profile was determined by SDS-23 
PAGE of S-layer proteins isolated using standard methods (see below). 24 
2 
Plasmid construction 25 
For crystallization studies, fragments of R7404 slpA, encoding mature HID (residues 1-41) 26 
and SLPL (residues 1-316) or LID (residues 240-316) were amplified from genomic DNA and 27 
cloned into pACYC-Duet1 yielding plasmids pJAK149 and pJAK147, respectively. C-terminally 28 
6x His-tagged HID was amplified using RF1396 and RF1397 and cloned into pACYC-Duet 29 
(MCS1) linearized using RF1398 and RF1400 by Gibson assembly, and SLPL or LID were 30 
amplified using RF1394 and RF1395 or RF1395 and RF1396, respectively, and cloned into 31 
MCS2 using NdeI-KpnI restriction cloning.  32 
To study protein-protein interactions in vitro, DNA encoding mature SLPL or SLPH of CD630 33 
and R7404 was amplified using Q5 (NEB) PCR and cloned into pET28a using NcoI-XhoI 34 
restriction cloning, in frame with a C-terminal 6x His-tag. Deletion variants (see Table 1 for 35 
construct details) lacking HID or LID, or point mutants within HID and LID were constructed 36 
by inverse PCR, using primers listed in Table 2, as previously described5. 37 
To study the impact of individual LID and HID point mutations on H/L complex assembly in C. 38 
difficile, codons for SLPL F274 or SLPH Y27 in pRPF170 were mutated to GCA (Ala) by inverse 39 
PCR cloning, yielding plasmids pRPF209 and pJAK186, respectively. 40 
 41 
Protein expression and purification 42 
S-layer was extracted as previously described6. Briefly, 400 ml of C. difficile CD630, R7404, 43 
RΔD2 16-hour culture were harvested by centrifugation at 4,696 × g for 30 min at room 44 
temperature. Cells were washed with 20 ml of phosphate buffered saline (PBS) pH 7.4, 45 
centrifuged for 10 min at 4,696 × g, and resuspended in 5 ml of 0.2 M glycine-HCl pH 2.2. 46 
Cell suspension was centrifuged at 21,100 × g for 10 min, and recovered supernatant was 47 
neutralized with 2 M Tris-base. S-layer extract was then filtered and resolved onto a 48 
3 
Superdex 200 26/600 column using an ÄKTA Pure FPLC system (GE Healthcare) in 10 mM 49 
Tris-HCl pH 7.5, 100 mM NaCl, 5 mM EGTA buffer. Protein eluate was analyzed by 12% SDS-50 
PAGE. 51 
BL21 (DE3) cells transformed with plasmids pJAK149 or pJAK147 were used to co-express 52 
HID-6x His-tag and SLPL or HID-6x His-tag and LID, in Auto Induction Media TB (Formedium) 53 
supplemented with 30 µg ml-1 chloramphenicol. Cells from 1 L of culture grown for 18h at 54 
37 °C were harvested by centrifugation at 4,000 × g, 4 °C for 30 min. Pellets were washed 55 
with PBS and frozen at -20 °C.  56 
Variants of SlpA subunits (Table 1) for interaction studies were expressed in Rosetta (DE3) 57 
cells, in 50 ml of Merck Novagen Overnight Express Instant TB Medium, supplemented with 58 
50 μg ml-1 kanamycin and 15 μg ml-1 chloramphenicol for 18 hours at 37 °C. Harvested cells 59 
were washed with PBS and frozen at -20 °C. 60 
Cell lysis for crystallography of recombinant proteins and interaction studies was performed 61 
using BugBuster Protein Extraction Reagent (Novagen). Pellets were resuspended to 62 
homogeneity in lysis buffer (50 mM Tris-HCl pH 8.0, 250 mM NaCl, 1x cOmplete EDTA-free 63 
protease inhibitors (Roche), 100 μg ml-1 lysozyme, 10 μg ml-1 DNase I, 1x BugBuster) and 64 
incubated at room temperature for 30 min. Extracts were centrifuged at 20,000 × g for 30 65 
min, supernatant was filtered and separated on a 5 ml HisTrap (GE Healthcare) column in 50 66 
mM Tris-HCl pH 8.0, 250 mM NaCl, 10 mM imidazole, with a linear gradient of imidazole (10-67 
500 mM). Eluate fractions were further purified using size exclusion chromatography on 68 
Superdex 75 (GE Healthcare) in 50 mM Tris-HCl pH 7.5, 150 mM NaCl.  69 
Variants of SLPH were recovered by affinity chromatography from isolated purified inclusion 70 
bodies, solubilized in 50 mM Tris-HCl pH 7.5, 500 mM NaCl and 8 M urea for 20 min at room 71 
temperature. Solubilized, cleared supernatant was loaded onto 5 ml HisTrap (GE Healthcare) 72 
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column in solubilization buffer, and column-bound protein was refolded in 50 ml of 50 mM 73 
Tris-HCl pH 7.5, 500 mM NaCl, 0.1% Triton X-100, followed by 50 ml of 50 mM Tris-HCl pH 74 
7.5, 250 mM NaCl, 5 mM β-cyclodextrin. Affinity purification was performed in 50 mM Tris 75 
pH 8.0, 250 mM NaCl, 10 mM imidazole, with protein elution by a linear gradient of 76 
imidazole (10-500 mM). Each chromatographic step was followed by analysis of the eluate 77 
by 12% SDS-PAGE. 78 
 79 
Protein analysis by western immunoblotting 80 
For analysis of H/L complex interactions on the surface of C. difficile, plasmids carrying a 81 
tetracycline-inducible copy of CD630 slpA (pRPF170) or derivatives with a point mutation in 82 
the LID (F274A, pRPF209) or the HID (Y27A, pJAK186) were transferred into the slpA-null 83 
strain FM2.5 by conjugation4. Strains were grown to an OD600nm of ~0.4 in TY broth and 84 
induced with anhydrotetracycline (20 ng ml-1). Surface-localized H/L subunits were extracted 85 
using low pH glycine as described above and normalized to an equivalent OD600nm of 25. 86 
Culture supernatants were filtered, concentrated to an equivalent OD600nm of 50 using a 87 
Vivaspin column with a 10 kDa MWCO. Samples were then subjected to SDS-PAGE and 88 
western immunoblotting using polyclonal antibodies specific for the CD630 SLPH or SLPL5. 89 
 90 
Analysis of protein-protein interactions by enzyme-linked immunosorbent assay (ELISA)  91 
The assays were performed as previously described5. Briefly, Maxisorp microtiter plates 92 
(Nunc) were coated with 10 μg ml-1 of SLPL or SLPH and their variants (Table 1), blocked with 93 
3% (w/v) milk in PBS with 0.05% (v/v) Tween-20, and overlaid with respective interacting 94 
partner, SLPL or SLPH, across 0.0001-100 μg ml-1 range. Binding was assessed with polyclonal 95 
rabbit primary antibodies against the overlay protein. Detection was carried out 96 
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spectrophotometrically by monitoring formation of product of horse radish peroxidase 97 
(HRP-conjugated secondary anti-rabbit antibody) with o-phenylenediamine dihydrochloride 98 
(OPD) upon addition of hydrogen peroxide to the reaction mix, with maximum of 99 
absorbance at 490 nm using Biotek ELx800 plate reader. 100 
 101 
X-ray crystallography 102 
Purified and concentrated proteins (recombinant LID/HID-6x His-tag at 38 mg ml-1 and 103 
SLPL/HID-6x His-tag at 20.9 mg ml-1, CD630, R7404 and RΔD2 H/L at 10 mg ml-1) were 104 
subjected to crystallization using a Mosquito liquid handling robot (TTP Labtech), with the 105 
sitting drop vapor-diffusion method at 20 °C. Native H/L complex crystallized in 0.1 MES pH 106 
6.0, 1.25 M lithium chloride, 16 PEG 6,000 and 10 % glycerol (v/v). Recombinant SLPL/HID-6x 107 
His-tag produced diffraction quality crystals in 0.2 M ammonium sulphate, 0.1 M MES pH 108 
6.5, 35% (v/v) MPD, while LID/HID-6x His-tag was crystallized in 1.6 M sodium citrate tribasic 109 
dihydrate pH 6.5. Data were collected on the I04 (λ= 0.98 Å), I23 (λ = 2.75 Å) and I24 (λ = 110 
0.93 Å) beamlines at the Diamond Light Source Synchrotron (Didcot, UK) at 100 K. The data 111 
were acquired from the automatic software pipeline xia2 within the Information System for 112 
Protein Crystallography Beamline (ISPyB), processed with XDS7, iMosflm8 or DIALS9 and 113 
scaled with Aimless10 within CCP4i11 or CCP4i212 software suites. When needed, density 114 
modification was performed with PARROT13. 115 
The structure of LID/HID-6x His was solved de novo using Arcimboldo_lite14 within CCP4i, 116 
starting from several 10-14 residues-long polyalanine models of α-helices. Automatic model 117 
building was performed with Buccaneer15, followed by manual building with Coot16 and 118 
refinement with Phenix_refine17. 119 
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The structure of SLPL/HID-6x His-tag was determined by sequential molecular replacement 120 
in Phaser18 searching first for SLPL  D1-D2 domains model (PDB ID: 3CVZ5), followed by the 121 
search with LID/HID structure into a fixed SLPL solution, and subsequent manual building 122 
(COOT) and refinement (Phenix_refine). 123 
Initial attempts to solve the substructure of the complete H/L complex by S-SAD provided 124 
only weak phases, and were improved by combining molecular replacement in Phaser using 125 
the CWB2 domain core of C. difficile Cwp8 (PDB ID: 5J6Q19) with sulphur anomalous 126 
difference Fourier maps using Anode20. This solution was used for MR-SSAD in 127 
Phenix.autosol and cycles of manual building in COOT and density improvement were used 128 
to improve the electron density maps and the model of the core SLPH. A complete H/L 129 
model was obtained by successive molecular replacement runs using Phaser in CCP4i2 130 
combining the SLPH model with the obtained LID/HID (PDB ID: 7ACW), D2 from SLPL/HID 131 
structure (PDB ID: 7ACV) and D1 (loops removed) from CD630 SLPL (PDB ID: 3CVZ). Presence 132 
of non-water solvent molecules was investigated with CheckMyBlob21. Final models were 133 
obtained after iterative cycles of manual model building with Coot and refinement in 134 
Phenix_refine and REFMAC522, with a final optimization step using PDB-REDO23, where 135 
relevant. Applied strategies included refinement of XYZ coordinates, real space, individual B-136 
factors, TLS parameters and occupancies. Structure of LID/HID consisted of 100% 137 
Ramachandran favored rotamers, SLPL/HID consisted of 98% Ramachandran favored and 2% 138 
Ramachandran allowed rotamers. Native protein structures of CD630, R7404 and RΔD2 H/L 139 
were modelled to 98%, 96%, 96% of Ramachandran favored and 0.2%, 0.2%, 0.1% of 140 
Ramachandran outlier rotamers, respectively. Full data collection and refinement statistics 141 
are summarized in SI Table 1. Validation of final models was performed using COOT and 142 
Phenix internal tools, as well as MOLPROBITY 24 web server. All structural models were 143 
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validated using wwPDB validation server prior to deposition of files. Data collection and 144 
refinement details are summarized in SI Table 1. Structural representations were generated 145 
using PyMOL Molecular Graphics System (Schrödinger, LLC) or Chimera25.  146 
 147 
Electron crystallography data collection 148 
To allow visualization by electron microscopy, S-layers were either removed from C. difficile 149 
cells in a single piece following peptidoglycan digestion (S-layer ghosts) or cells were 150 
mechanically fragmented (S-layer/cell wall fragments). C. difficile cells were harvested by 151 
centrifugation and resuspended to an OD600 of 10 in 20 mM HEPES pH 7.5, 150 mM NaCl, 152 
500 mM sucrose. For S-layer ghosts, cell walls were digested using purified ϕCD27 endolysin 153 
for 30 min at 37 °C26. The resulting membrane-bound spheroplasts were removed from the 154 
sample by centrifugation at 2,000 × g for 2 min and the supernatant, containing S-layer 155 
ghosts, was retained for imaging. 5 μl of S-layer ghosts were loaded on glow-discharged, 156 
amorphous carbon-coated 300 mesh copper EM grids and stained with 2% uranyl acetate, 157 
as previously described27. Samples were examined on a Phillips CM200 FEG transmission 158 
electron microscope at 200 kV. Images were collected on a 4096 x 4096 pixel Gatan 159 
UltraScan 4000SP Model 890 CCD camera (Gatan Inc.), with 15 µm pixel size. A total of 36 160 
micrographs of R20291 and 29 micrographs for RΔD2 S-layer extracts were collected at a 161 
magnification of 82351 x and defocus range from -800 to -2200 nm. The specimen tilt angle 162 
ranged from −55° to +55° in increments of 10°.  163 
 164 
For cryo-EM, fragments of S-layers were generated by mechanical disruption. Briefly, 60 ml 165 
of C. difficile cells at OD600nm 0.6 - 0.8 were centrifuged at 2,000 × g for 15 min at 4 °C. The 166 
cell pellet was washed twice in cold deionized water and combined with an equal volume of 167 
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pre-cooled acid-washed glass beads (Sigma) and homogenized in a Braun MSK homogenizer 168 
for 30 s. The homogenate was cooled and centrifuged at 800 × g for 10 min to remove glass 169 
beads and unbroken cells. S-layer fragments were then harvested at 3000 × g for 10 min, 170 
washed with cold 1 M NaCl and resuspended in cold 2% (v/v) Triton X-100. 2.5 µl of the S-171 
layer fragments were added to glow-discharged Quantifoil® 2/2 grids. The grids were then 172 
blotted for 30 s and plunged into liquid ethane, using a Vitrobot Mark III (FEI). The frozen 173 
grids were stored in liquid nitrogen for later observation. Micrographs, at 68,000 x 174 
magnification and defocus range of -2000 to -3000 nm, were obtained on a Falcon II direct 175 
electron detector (FEI) using a Tecnai F20 microscope (FEI) operating at 200 keV.  176 
 177 
Electron crystallography data processing 178 
Images were initially processed using the 2dx suite28-30. Most micrographs of S-layer ghosts 179 
showed two rotationally separated lattices in Fourier transforms and these were indexed 180 
independently. Images were masked based on crystal size and good crystalline order and 181 
subjected to two cycles of unbending using the programs QUADSEARCH and CCUNBEND. 182 
The symmetry was determined from images of untilted crystals using ALLSPACE31. Phase 183 
origins for individual images were refined against each other using ORIGTILTK, sequentially 184 
adding images of higher tilt to the refinement. Crystal tilt angles were estimated from lattice 185 
distortion. LATLINE32 was used to determine interpolated amplitudes and phases on a 186 
regular lattice of 1/160 Å−1 in the z* direction. A Gaussian tapered real-space envelope of 187 
width slightly larger than that of the H/L complex estimated from the X-ray crystal structure 188 
(70 Å for wild type and 60 Å for RΔD2) was applied. The phase origin and tilt parameters 189 
were further refined using the output interpolated lattice lines as reference. The variation of 190 
amplitude and phase along 0,0,l was estimated by examining a plot of maximum contrast on 191 
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each Z-section in real space33. The final structure factors were sampled from the 192 
interpolated lattice lines32 and a 3D map generated within the CCP4 suite of programs11,28. 193 
Cryo-EM micrographs of untilted R20291 and RΔD2 samples were processed similarly to 194 
generate 2D projection maps. B-factors were calculated using SCALIMAMP3D with 195 
bacteriorhodopsin diffraction amplitudes as reference34. Data collection, processing and 196 
analysis details are summarized in SI Tables 2 and 3. 197 
 198 
Fitting X-ray structures to EM density 199 
The coordinates of R20291 and RΔD2 H/L complex X-ray structural models were fitted using 200 
Chimera 1.13.125 into the wild type and mutant electron microscopy reconstructions. The 201 
extended lattice of each H/L complex was generated by calculating symmetry-related 202 
molecules from the crystal packing in PyMOL, and then manually orienting them in the EM 203 
density, based on the known surface orientation i.e. SLPL facing the environment, and SLPH 204 
facing the cell wall. The ‘Fit in map’ function was then used to calculate the highest 205 
correlation to a map simulated from the X-ray structure coordinates at 20 Å resolution. 206 
 207 
Tomography 208 
For cryo-electron tomography (cryo-ET), the homogenized S-layer ghost sample used in 209 
electron crystallography was mixed with an equal volume of 10 nm BSA-treated nanogold 210 
beads, and 3 μl of this mixture was applied to a glow discharged lacey carbon with ultra-thin 211 
carbon 300 mesh grid, blotted for 3 s and plunged into liquid ethane, using a Leica EM GP. 212 
The frozen grids were stored in liquid nitrogen temperature for later observation. Tilt series 213 
were collected on a Titan Krios microscope operating at 300 keV with a GIF Quantum energy 214 
filter, Volta phase plate, and K2 camera operating in super-resolution mode. Micrographs 215 
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were collected using SerialEM, at a pixel size of 5.47 Å, with each tilt series covering ± 60° 216 
with a tilt increment of 3°, and collected with a grouped dose-symmetric acquisition scheme 217 
and group sizes of 4. Samples from each tilt series received 100 e/Å2 total dose with 20 218 
frames per tilt. Tomograms were constructed using the IMOD package35. Tilt series were 219 
tracked and aligned based on fiducial markers, and then tomograms were reconstructed by 220 
weighted back projection with 1x binning. 221 
 222 
 Analysis of sporulation and resistance to lysozyme 223 
Quantitative analysis of sporulation efficiency was performed as described previously36. 224 
Overnight stationary phase cultures were first diluted to an OD600nm of 0.01, grown for 8 225 
hours before a second dilution to an OD600nm of 0.0001. Following overnight growth, the 226 
resulting stationary phase culture (T=0) was then incubated. After 5 days, the proportion of 227 
vegetative cells and spores was determined; total and heat-resistant (65 °C for 30 min) 228 
colony forming units (CFUs) were enumerated in BHI-S agar supplemented with 0.1% (w/v) 229 
taurocholate. Assays were repeated in triplicate with biological triplicates. 230 
To assess resistance to lysozyme, overnight C. difficile cultures were grown in TY broth, 231 
subcultured to an OD600nm of 0.05 in 1 ml fresh TY in a 1.5 ml cuvette and then grown for 8 h 232 
with hourly OD600nm measurements. Where appropriate, lysozyme (500 μg ml-1) was added 233 
after 2.5 h growth. Experiments were performed in triplicate on biological duplicates and 234 
data expressed as the mean and standard deviation. 235 
 236 
Animal experiments 237 
All procedures were performed in strict accordance with the Animals (Scientific Procedures) 238 
Act 1986 with specific approval granted by the Home Office, UK (PPL60/8797). C57/Bl6 239 
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specific pathogen free female mice aged 6 - 8 weeks were supplied by Charles River 240 
(Edinburgh). Animals were housed within individual sterilized ventilated cages (IVCs) in 241 
groups of five. Sterilized food and water were provided ad libitum and animals kept at a 242 
constant room temperature of 20 - 22 °C with a 12 hour light/dark cycle. To limit the impact 243 
of cage effects, experiments (n = 5 mice) were performed at least in duplicate using animals 244 
delivered on different dates. Animals were prepared for C. difficile challenge by provision of 245 
an antibiotic cocktail (0.035 mg ml-1 gentamycin, 0.4 mg ml-1 kanamycin, 850 U ml-1 colistin, 246 
0.215 mg ml-1 metronidazole, 0.045 mg ml-1 vancomycin) administered ad libitum in the 247 
drinking water for 3 days37. Clindamycin (150 mg kg-1) was then given by oral gavage the 248 
following day. Mice were rested for two days without antibiotic administration before 249 
challenge of each animal with 106 spores of C. difficile delivered by oral gavage. Daily 250 
relative weight loss was determined by dividing individual daily weights by the weight of 251 
each mouse prior to challenge.  Animals with a weight loss greater than 15% were culled. C. 252 
difficile colonization was quantified through the serial dilution and culturing of fresh faecal 253 
material collected from individual animals or from caecal and colonic samples prepared at 254 
the time of cull. These were generated by opening the tissue longitudinally and recovering 255 
the contents by washing the tissue in 5 ml or 2 ml of PBS. respectively. Colony forming units 256 
were calculated from counts generated from diluted samples from individual animals and 257 
results reflect the median of a minimum of n = 5 mice at each time point.   258 
 259 
Tissue histology 260 
Histological samples were harvested from the cecum at 48 h (peak of infection) and 261 
immediately fixed in 10% formalin. Embedded tissue sections were cut and stained with 262 
hematoxylin and eosin. The histological severity was graded using an adapted scoring 263 
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system accounting for: a. epithelial damage, b. neutrophil margination and tissue 264 
infiltration, c. hemorrhagic congestion and tissue edema, and d.  crypt hyperplasia. At least 265 
six independent fields of view (a maximum of three taken from any individual animal) were 266 
examined.  Scores for each parameter were assigned for each feature (1, mild; 2, moderate; 267 
3, significant; 4, severe).  Cumulative scores reflect the sum of each scored feature.  268 
 269 
Toxin activity 270 
Toxin activity in caecal and colonic contents collected at post-mortem was determined by 271 
measurement of cytotoxic activity on cultured cells. Activity of the toxins produced in vitro 272 
was also analyzed from spent culture supernatant taken from TY culture at 5, 24 and 48 h. 273 
Samples from both in vivo and in vitro experiments were filtered (0.2 μm), serially diluted 274 
and applied to monolayers of Vero cells (Toxin B), as described previously38. Each sample 275 
was analyzed minimally in two independent experiments, with samples collected from a 276 
minimum of n = 5 mice per time point. 277 
For direct detection of toxin in vitro, 48 h culture supernatants were filtered using a 0.44 µm 278 
filter and concentrated to an equivalent OD600nm of 50 using a Vivaspin column with a 10 279 
kDa MWCO. Concentrated samples were separated by SDS-PAGE, electroblotted to PVDF 280 
membrane and probed using a specific mouse monoclonal antibody (Toxin B: MA1-7413, 281 
Thermo Fisher). 282 
 283 
Other methods 284 
PDBeFold39 was used to search for homologous structures and to compare the similarity 285 
between models determined in this study. PISA40, PDBSum41 and LigPlot+42 were used to 286 
investigate interdomain and protein-protein interfaces. Structural flexibility of models was 287 
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assessed by DynDom6D (v1.0 with default settings43), HingeProt webserver44 and the 288 
components of DynOmics webserver.  289 
Evolutionary conservation of SlpA across the unique annotated SLCTs retrieved from the  290 
Clostridioides difficile Multi Locus Sequence Typing database 291 
(https://pubmlst.org/bigsdb?db=pubmlst_cdifficile_seqdef&page=alleleQuery&locus=slpA&292 
submit=1) was performed in the ConSurf version 3.0 server45, using the structural model of 293 
the CD630 H/L complex (PDB ID: 7ACY) to map the conservation scores onto 3D crystal 294 
structure. Conservation scores were calculated with the Bayesian method, using the WAG 295 
model of amino acid substitution (selected based on ProtTest 3.4.1). 296 
Representatives of each SLCT, as defined previously3, were used to analyze conservation of 297 
structural features and H/L interactions. Sequences were aligned using Clustal Omega, with 298 
secondary structure assignment from the CD630 H/L structural model as defined in 299 
PDBSUM. Structural models for SLCT representatives were generated with SWISS-MODEL 300 
webserver using the H/L complex crystal model as a user provided template. Structural 301 
alignments between homology model and template were performed using SSM algorithm in 302 
Coot. Data was mined using Numpy (v1.16.6)46 Pandas (v0.24.2)47 and the heatmap 303 
generated with Seaborn (v0.10.1)48. 304 
For SI SLCT sequence alignment, protein sequences for SlpA representatives used to 305 
generate homology models were aligned in Clustal Omega49 with default settings. 306 
Secondary structure information from CD630 H/L complex was added to alignment by 307 
ESPript350. Manual annotations were added to the figure for clarification on subunits, 308 
domains and position of interacting residues. 309 
Analysis of pores in the H/L array was carried out using ChexVis51 and hydrophobicity 310 
patterns for residues lining each pore calculated using the Kyte-Doolittle scale52. 311 
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 312 
Data availability 313 
Crystal structures were deposited in Protein Data Bank with PDB IDs 7ACW (LID/HID), 7ACV 314 
(SLPL/HID), 7ACX (H/L, R7404), 7ACY (H/L, CD630) and 7ACZ (H/L, RΔD2). 315 
 316 
Statistical analysis 317 
Statistical analysis was carried out in GraphPad Prism 8. Non-parametric, non-paired Mann-318 
Whitney test results were considered.  319 
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Table 1. Bacterial strains and plasmids used in x-ray crystallography and protein-protein 470 
interaction studies. 471 
Strain or 
plasmid 
Description 
Reference/ Source 
Application 
C. difficile strains 
CD630 Ribotype 012, SLCT-7 53 
R20291 Ribotype 027, SLCT-4 54 
FM2.5 R20291 slpA 282_283insA 3 
RΔD2 FM2.5 slpAΔD2 This study 
R7404 Ribotype 017, SLCT-7b 55 
E. coli strains 
NEB5a 
fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
New England Biolabs 
BL21 (DE3) 
E. coli str. B F– ompT gal dcm lon 
hsdSB(rB–mB–) λ(DE3 [lacI lacUV5-T7p07 
ind1 sam7 nin5]) [malB+]K-12(λS) 
Novagen 
Rosetta (DE3) 
F- ompT hsdSB(rB- mB-) gal dcm (DE3) 
pRARE (CamR) 
Novagen 
Plasmids 
pOB001 pMTL960-Ptet-slpAΔD2 (R20291) 
This study.  
RF102/ RF103 
pRPF170 pMTL960-Ptet-slpA (CD630) 
This study.  
NF1414/ NF1415 
pRPF233 pMTL960-Ptet-slpA (R20291) 3 
Plasmids for recombinant expression of mature protein 
pABS17 pET28a-LMW-6xHis-tag (R20291) 
This study.  
LMW of R20291;  
oABS46/ oABS47 
pABS18 pET28a-HMW-6xHis-tag (R20291) 
This study. HMW of R20291; 
oABS44/ oABS45 
pABS19 pET28a-LMW-6xHis-tag (R7404) 
This study. LMW of R7404; oABS1/ 
oABS2 
pABS20 pET28a-HMW-6xHis-tag (R7404) 
This study. HMW of R7404; 
NcoI/XhoI subcloning from 
pJAK148 into pET28a 
23 
pABS21 pET28a-LMWDLID-6xHis-tag (R20291) 
This study. LMW of R20291; 
oABS31/oABS48 
pABS22 pET28a-HMWDHID-6xHis-tag (R20291) 
This study. HMW of R20291; 
oABS15/oABS16 
pABS23 pET28a-LMWDLID-6xHis-tag (R7404) 
This study. LMW of R7404; 
oABS31/oABS32 
pABS24 pET28a-HMWDHID-6xHis-tag (R7404) 
This study. HMW of R7404; 
oABS39/oABS16 
pHMW630 pET28a-HMW-6xHis-tag (CD630) 5 HMW of CD630 
pHMWΔ1-40 pET28a-HMWΔLID-6xHis-tag (CD630) 
5 HMW of CD630 lacking the N 
terminal HID 
pLMW630 pET28a-LMW-6xHis-tag (CD630) 5 LMW of CD630 
pLMWΔ260-321 pET28a-LMWΔHID-6xHis-tag (CD630) 
5 LMW of CD630 lacking the C 
terminal LID 
pJAK149 pETDuet-1-HID-6xHis-tag – LMW (R7404) 
This study. Recombinant co-
expression of mature LMW/HID of 
R7404; RF1396/ RF1397, RF1398/ 
RF1400, RF1394/ RF1395 
pJAK147 pETDuet-1-HID-6xHis-tag – LID (R7404) 
This study. Recombinant co-
expression of mature LID/HID of 
R7404; RF1396/ RF1397, RF1398/ 
RF1400, RF1395/ RF1396 
Plasmids for expression of the mature protein with a point mutation in the interaction domain, 
as specified in subscript 
pABS1 pET28a-LMWF274A-6xHis-tag (CD630) This study. oABS33/ oABS34 
pABS2 pET28a-HMWY27A-6xHis-tag (R20291) This study. oABS37/ oABS38 
pABS3 pET28a-LMWF273A-6xHis-tag (R20291) This study. oABS35/ oABS36 
pABS4 pET28a-HMWY27A-6xHis-tag (R7404) This study. oABS5/ oABS6 
pABS5 pET28a-LMWF270A-6xHis-tag (R7404) This study. oABS21/ oABS22 
pABS6 pET28a-HMWN19A-6xHis-tag (R7404) This study. oABS3/ oABS4 
pABS7 pET28a-HMWD29A-6xHis-tag (R7404) This study. oABS7/ oABS8 
24 
pABS8 pET28a-HMWL31A-6xHis-tag (R7404) This study. oABS9/ oABS10 
pABS9 pET28a-HMWN35A-6xHis-tag (R7404) This study. oABS11/ oABS12 
pABS10 pET28a-HMWS39A-6xHis-tag (R7404) This study. oABS13/ oABS14 
pABS11 pET28a-LMWD254A-6xHis-tag (R7404) This study. oABS17/ oABS18 
pABS12 pET28a-LMWI259A-6xHis-tag (R7404) This study. oABS19/ oABS20 
pABS13 pET28a-LMWY279A-6xHis-tag (R7404) This study. oABS23/ oABS24 
pABS14 pET28a-LMWG300A-6xHis-tag (R7404) This study. oABS25/ oABS26 
pABS15 pET28a-LMWF306A-6xHis-tag (R7404) This study. oABS27/ oABS28 
pABS16 pET28a-LMWR309A-6xHis-tag (R7404) This study. oABS29/ oABS30 
pHMW_Y27A pET28a-HMWY27A-6xHis-tag (CD630) This study. NF1386/ NF1387 
pJAK186 pMTL960 Ptet-slpA HMWY27A (CD630) This study. NF1386/ NF1387 
pRPF209 pMTL960-Ptet-slpA LMWF274A (CD630) This study. NF1189/ NF1190 
 472 
 473 
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 475 
Table 2. Oligonucleotides used in this study. 476 
Name Sequence Application 
oABS1 GATCCCATGGCAGATAGTAC 
Amplification of LMW R7404 
with NcoI site forward primer 
oABS2 GATCCTCGAGAGATTTAGTTTC 
Amplification of LMW R7404 
with XhoI site reverse primer 
oABS3 GCTAAATTAAAAGATTTAAAAGATTATGTAG 
Introduction of N19A point 
mutation in R7404 HMW 
oABS4 AGCTTTTATAGTTATTTTAGCTGG 
Introduction of N19A point 
mutation in R7404 HMW 
oABS5 GCTGTAGATGATTTAAAAACATAC 
Introduction of Y27A point 
mutation in R7404 HMW 
oABS6 ATCTTTTAAATCTTTTAATTTATTAGC 
Introduction of Y27A point 
mutation in R7404 HMW 
oABS7 GCTGATTTAAAAACATACAATAATAC 
Introduction of D29A point 
mutation in R7404 HMW 
oABS8 TACATAATCTTTTAAATCTTTTAATTTATTAG 
Introduction of D29A point 
mutation in R7404 HMW 
oABS9 GCTAAAACATACAATAATACTTACTCAAATG 
Introduction of L31A point 
mutation in R7404 HMW 
oABS10 ATCATCTACATAATCTTTTAAATCTTTTAATTTATTAG 
Introduction of L31A point 
mutation in R7404 HMW 
oABS11 GCTAATACTTACTCAAATGTTGTAAC 
Introduction of N35A point 
mutation in R7404 HMW 
oABS12 GTATGTTTTTAAATCATCTACATAATC 
Introduction of N35A point 
mutation in R7404 HMW 
oABS13 GCAAATGTTGTAACAGTAGCAG 
Introduction of S39A point 
mutation in R7404 HMW 
oABS14 GTAAGTATTATTGTATGTTTTTAAATCATC 
Introduction of S39A point 
mutation in R7404 HMW 
oABS15 GCGCGCACAGTAGCAGGAGAAGATAGAATAG Deletion of HID in R7404 HMW 
oABS16 CATGGTATATCTCCTTCTTAAAGTTAAAC 
Deletion of HID in HMW (R7404, 
R20291) 
oABS17 GCTTCAAGTTCATATATTAGTGC 
Introduction of D254A point 
mutation in R7404 LMW 
oABS18 CACATCAATAGATTCTTCTTTTGC 
Introduction of D254A point 
mutation in R7404 LMW 
oABS19 GCTAGTGCTGAAAATTTAGC 
Introduction of I259A point 
mutation in R7404 LMW 
oABS20 ATATGAACTTGAATCCACATC 
Introduction of I259A point 
mutation in R7404 LMW 
26 
oABS21 GCTAATCCTAAAGAGGTTTCTG 
Introduction of F270A point 
mutation in R7404 LMW 
oABS22 TACATATTTTTTAGCTAAATTTTCAGCAC 
Introduction of F270A point 
mutation in R7404 LMW 
oABS23 GCTAATGCAATAGTTGCATTAC 
Introduction of Y279A point 
mutation in R7404 LMW 
oABS24 AGCTTCAGAAACCTCTTTAGG 
Introduction of Y279A point 
mutation in R7404 LMW 
oABS25 GCAAAATATCAAGTTATTTTCTATCC 
Introduction of G300A point 
mutation in R7404 LMW 
oABS25 ATTAACTAATTGTACTAAATCAGATTC 
Introduction of G300A point 
mutation in R7404 LMW 
oABS27 GCTTATCCAGAAGGAAAAAGATTAG 
Introduction of F306A point 
mutation in R7404 LMW 
oABS28 AATAACTTGATATTTTCCATTAACTAATTGTAC 
Introduction of F306A point 
mutation in R7404 LMW 
oABS29 GCATTAGAAACTAAATCTCTCG 
Introduction of R309A point 
mutation in R7404 LMW 
oABS30 TTTTCCTTCTGGATAGAAAATAAC 
Introduction of R309A point 
mutation in R7404 LMW 
oABS31 GCGCGCCTCGAGCACCACCACCAC 
Deletion of LID in LMW (R7404, 
R20291) 
oABS32 TTTTATAGTACCTGTTGCAGCCATATC Deletion of LID in R7404 LMW 
oABS33 GCTGATCCAGATGAAATTTCTG 
Introduction of F274A point 
mutation in CD630 LMW 
oABS34 TACATATCTTTTAGCTAAATTTTCAGC 
Introduction of F274A point 
mutation in CD630 LMW 
oABS44 GATCCCATGGCTGCAAAGGCTTCAATTGCTG 
Amplification of HMW R20291 
with NcoI site forward primer 
oABS45 
GATCCTCGAGCATACTTAATAAATCTTTT 
AATTTATTTATAACTG 
Amplification of HMW R20291 
with XhoI site reverse primer 
oABS46 GATCCATGGCAGAAGATATGTCGAAAGTTG 
Amplification of LMW R20291 
with 5  NcoI site 
oABS47 GATCCTCGAGACTCTTAGTTGTAACTCTTTTTCC 
Amplification of LMW R20291 
with 3  XhoI site 
oABS48 AGTTATTACTGGGCTTCCAGATTGTG 
Introduction of deletion of LID in 
R20291 LMW 
oABS35 GCTAATAAAACAGATTTAAATACTCTTTAC 
Introduction of F273A point 
mutation in R20291 LMW 
oABS36 TACATATTTTTTAGCTAAATCTTGTGCTG 
Introduction of F273A point 
mutation in R20291 LMW 
oABS37 GCTGTGGATGATTTAAGAACATATAATAATG 
Introduction of Y27A point 
mutation in R20291 HMW 
27 
oABS38 ATCTTTTAAGTCTTTCTTCTTATCTGAC 
Introduction of Y27A point 
mutation in R20291 HMW 
oABS39 GCGCGCGAAGTAGCAGGAGAAGATAG Deletion of HID in R20291 HMW 
oABS40 GCTAGAACATATAATAATGGATATTCAAATG 
Introduction of L31A point 
mutation in R20291 HMW 
oABS41 ATCATCCACATAATCTTTTAAGTCTTTC 
Introduction of L31A point 
mutation in R20291 HMW 
oABS42 GCTAAAACATATAATAATACTTATTC 
Introduction of L31A point 
mutation in CD630 HMW 
oABS43 ATCATCTACATAATCTTTTAAATC 
Introduction of L31A point 
mutation in CD630 HMW 
NF1189 GCAGATCCAGATGAAATTTCTGAAGC 
Introduction of F274A point 
mutation in CD630 LMW 
NF1190 TACATATCTTTTAGCTAAATTTTCAGCTG 
Introduction of F274A point 
mutation in CD630 LMW 
NF1386 
GCAGTAGATGATTTAAAAACATATAATAATACTTAT
TC 
Introduction of Y27A point 
mutation in CD630 HMW 
NF1387 ATCTTTTAAATCTTTTAATTTATTAGCTTTTATAAC 
Introduction of Y27A point 
mutation in CD630 HMW 
NF1414 
GATCGAGCTCTATAATGTTGGGAGGAATTTAAGAA
ATG 
Amplification of slpA from CD630 
with 5  SacI site 
NF1415 
GATCGGATCCTTACATATCTAATAAATCTTTCATTTT
G 
Amplification of slpA from CD630 
with 3  BamHI site 
RF102 GGTTCTGGAAGCCCAGTAATAACTAAAC 
Replacement of coding sequence 
of LMW domain 2 with GGA GGT 
RF103 TCCAGAGCTTATTAAGAAATCTACATAATCC 
Replacement of coding sequence 
of LMW domain 2 with GGA GGT 
RF1393 GATCCATATGGCAGATAGTACTACGCCAGG 
Amplification of LMW for 
insertion into pACYC-Duet1 
RF1394 
GATCGGTACCTTAAGATTTAGTTTCTAATCTTTTTCC
TTCTG 
Amplification of LID and LMW for 
insertion into pACYC-Duet1 
RF1395 GATCCATATGGTTAGAGTTACAAGTGCAAAAGAAG 
Amplification of LID for insertion 
into pACYC-Duet1 
RF1396 CATGGTATATCTCCTTATTAAAGTTAAAC 
Linearization of pACYC-Duet1 for 
insertion of HID 
RF1397 CTCGAGCACCACCACCAC 
Linearization of pACYC-Duet1 for 
insertion of HID 
RF1398 
TGTTTAACTTTAATAAGGAGATATACCATGGCAGAT
ATAATAGCTGATGCAG 
Amplification of HID for insertion 
into pACYC-Duet1 
RF1400 
ATCTCAGTGGTGGTGGTGGTGGTGCTCGAGTACAA
CATTTGAGTAAGTATTATTGTATG 
Amplification of HID for insertion 
into pACYC-Duet1 
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Supplementary Information – Discussion 1 
 2 
Our structural models and functional analysis of the S-layer of C. difficile provide the first 3 
detailed insights of this important layer in a human pathogenic bacterium. This work allows 4 
us to explore this array in unprecedented detail, both elucidating key features and raising 5 
new questions requiring further investigation. 6 
 7 
S-layer assembly: how can a 2D crystal array remain flexible?  8 
A degree of conformational flexibility is required to accommodate the wrapping of the 2D S-9 
layer lattice around the curved surface of the C. difficile cell. Indeed, dynamic flexibility 10 
between S-layer protein domains has been shown to promote efficient crystal nucleation on 11 
the curved cellular surface in Caulobacter crescentus1. Our recent work showed formation of 12 
C. difficile S-layer at specific sites coinciding with cell wall synthesis2, suggesting discrete S-13 
layer assembly points. Furthermore, Fourier analysis of S-layer ghosts and tomographic 14 
imaging (Extended Data Fig. 10) indicates a highly mosaic surface, with many crystal defects, 15 
particularly at the cell poles, where the paracrystalline array must be disrupted to allow for 16 
cell curvature. The pattern of crystalline patches with grain boundaries observed is 17 
consistent with the random secretion of S-layer protein monomers and self-assembly of 2D 18 
crystals occurring at gaps and grain boundaries within the curved S-layer, as proposed for 19 
other organisms3-5. 20 
 21 
While increasing numbers of S-layer structural models are available6-11, to our knowledge, 22 
this is the first report of a complete X-ray structure of a major S-layer protein where the 23 
crystal lattice mimics S-layer assembly in the cell. This indicates that S-layer assembly in C. 24 
 2 
difficile does not require an underlying ordered polysaccharide array, unlike the apparent 25 
organization observed in LPS-mediated S-layer anchoring in the Gram-negative C. 26 
crescentus10. As the C. difficile S-layer is anchored via interactions of the CWB2 motifs with 27 
PSII12, a much simpler glycan that is unlikely to be ordered at the cell surface, it is not 28 
surprising that the protein can assemble independently. In order to elucidate the anchoring 29 
mechanisms of C. difficile S-layer, we are investigating the interactions of SPLH and the H/L 30 
complex with PSII using a combination of biochemical, biophysical and structural methods.  31 
 32 
 SlpA is the main component of the S-layer in C. difficile but additional proteins, which 33 
together correspond to an estimated 10% of the protein molecules forming the array, must 34 
be accommodated within the layer. Our assembly model suggests that tiling of the CWB2 35 
triangular prism present in SLPH and in all minor cell wall proteins (CWPs)13, is a mechanism 36 
that allows insertion of these proteins while maintaining the crystalline arrangement. In our 37 
crystal structure, SLPH tiling is maintained by charge complementarity of interacting 38 
triangular prism surfaces (Extended Data Fig. 3b). Our structural analysis of homology 39 
models of other SLCTs suggests that most of the interactions between neighbouring H/L 40 
complexes which define those interfaces are conserved across different SLCTs (Extended 41 
Data Fig. 4), indicating that they are likely to be important for C. difficile S-layer assembly. It 42 
is worth noting that the most conserved interactions are at the interface of neighbouring 43 
CWB23-CWB21 motifs and around pore 2, and involve residues from both SLPH and SLPL 44 
(Extended Data Fig. 4b, top 6 rows). This conservation across SLCTs suggests that SLPL is also 45 
important to maintain the S-layer assembly and that these interactions could be potential 46 
targets for disrupting the array. 47 
 3 
Our analysis of the charge distribution of the CWB2 motifs in Cwp6 and Cwp8, the only 48 
other CWB2-containing proteins whose structures have been determined to date14, 49 
indicates that the charge complementarity between H/L complex and these minor S-layer 50 
components would also be possible, supporting our proposed global assembly model. The 51 
specific insertion points of additional CWPs are yet to be determined and it is possible that 52 
these regions could create other mismatch points that would allow growth, accommodate 53 
curvature and confer flexibility to the S-layer.  54 
This proposed model for insertion of additional proteins via tiling of CWB2 motifs raises the 55 
question of how the accessory domains in CWPs are incorporated in the SLPL ridge features. 56 
Homology between CWPs and SlpA is restricted to the CWB2 trimeric motif  as CWPs have 57 
distinct accessory domains replacing the SLPL13. These structurally diverse domains have to 58 
be accommodated in the S-layer, in order to maintain the integrity of the crystalline array. 59 
Based on the observation that most of the X-ray crystallographic model of the H/L complex 60 
fits well into the envelope defined by the EM reconstruction, with the exception of the D2 61 
domain, we speculate that this region of SLPL might confer further flexibility to the 62 
assembled S-layer. It is also possible that D2 adopts a slightly different position relative to 63 
SLPH in the mature S-layer as it could be better accommodated into the EM envelope, in the 64 
region corresponding to missing density in the SlpARΔD2 reconstruction, by a shift of 10° 65 
relative to D1 (Extended Data Fig. 6). Indeed, strikingly different conformations of the D1-D2 66 
domains in SLPL are observed in the H/L and SLPL/HID structural models (Extended Data Fig. 67 
2). Analysis of the architecture and simulated motions (DynDom6D v1.0) in these models 68 
identified regions of D1-D2 and LID/HID as two dynamic domains, with the linker between 69 
the D1 C-terminal b-strand and LID N-terminal b-strand acting as interdomain hinge 70 
residues (Extended Data Fig. 2). The calculated rotation angle of the centers of mass of the 71 
 4 
D1-D2 region relative to LID/HID of 166° suggests a high degree of flexibility of these 72 
regions, at least in the absence of the CWB2-containing SLPH core, with minimal effects on 73 
the fold of each individual domain. Together, these observations suggest that D2 could 74 
adopt a number of conformations in the mature S-layer, therefore facilitating the insertion 75 
of other S-layer proteins.  76 
 77 
S-layer as a molecular sieve: how do molecules go in or out? 78 
S-layers have been proposed to act as a molecular filter15  but the bulk of the C. difficile cell 79 
surface seems virtually impenetrable to large molecules, even though cells appear to be 80 
able to secrete toxin even in the absence of cell lysis16. The pores we observe in situ would 81 
not allow for most proteins to directly diffuse in or out. Whether mismatch regions in the 2D 82 
paracystalline array (Extended Data Fig. 10) are sufficient for access and how these 83 
processes can be controlled are key questions to pursue to further our understanding of S-84 
layer in C. difficile.  85 
The pores observed in our crystal lattice (Fig. 3) are highly hydrophilic (Extended Data Fig. 86 
3e), suggesting most small charged molecules could diffuse into the cell. Pore 1, mostly 87 
occluded by D2 in the full H/L complex, has a mixed charged distribution, with patches of 88 
both positive and negative charges throughout (Extended Data Fig. 3f), suggesting 89 
important metabolites such as ATP (negatively charged) or metal ions (positively charged) 90 
could have access. In contrast, the fully exposed pore 2, is mostly negatively charged, 91 
indicating that positively charged small metabolites could preferably be diffused via this 92 
pore. The presence of a positive patch formed by two pseudo symmetry-related lysines 93 
covering the outermost opening of this pore (Extended Data Fig. 3f) could provide a gating 94 
mechanism for these metabolites.  95 
 5 
It is worth noting that interacting D1 domains from neighbouring SLPL molecules completely 96 
cover the widest cavity in the SLPH CWB2s tiling. This interface, defined by neighbouring 97 
CWB21-CWB22 motifs, at around 20 Å wide but spanning over 100 Å across the triangular 98 
prism tiles, is also hydrophilic, with complimentary charges (Extended Data Fig. 3b). The 99 
SLPH CWB2 motifs tiling also creates a cavity of approximately 70 Å between symmetry-100 
related molecules which is partly occluded by the HID and LID domains, with the 101 
interlocking D1 domain ridges covering this gap (Extended Data Fig. 3b). If the interacting D1 102 
domains are flexible and can at least partially expose these cavities, it could potentially 103 
allow diffusion of larger molecules through the S-layer. 104 
Absence of D2 creates a more permeable S-layer as it exposes pore 1 in the SLPH tiling (Fig. 105 
3, Extended Data Fig. 3). Moreover, many of the residues lining the two exposed pores in 106 
this lattice are not resolved in the electron density of the SlpARΔD2 and could not be 107 
modelled, suggesting weaker interactions. A scenario where D1-LID/HID interactions with 108 
the CWB2s are less stable and could allow access to the wider openings in the CWB2s tiles 109 
would possibly explain the susceptibility to lysozyme seen in the RΔD2 strain (Extended Data 110 
Fig. 8). It would also point to a role of the D2 domain in preventing access of at least some 111 
antimicrobials and this could relate to the reduced disease severity observed for RΔD2. 112 
 113 
S-layer role in disease: potential mechanism 114 
Our work with RΔD2 strain, producing a modified S-layer is, as far as we are aware, the first 115 
example of a C. difficile strain exhibiting both similar toxin and colonization levels but 116 
reduced disease severity in a mouse model. The reduction in weight loss upon infection with 117 
a strain of C. difficile lacking the surface-exposed D2 domain of SLPL suggests that the S-layer 118 
and toxins act synergistically to mediate epithelial damage, highlighting the possible 119 
 6 
contribution of the S-layer in delivery of toxin and enhancement of cellular responses 120 
important for disease severity. Toxins have been shown to be essential for C. difficile 121 
disease17,18 and their role in glucosylation of small GTPases and key structural features have 122 
been elucidated19. Toxin activity has also been linked to inflammatory influx through 123 
activation of the inflammasome20. While the specific contribution of the D2 domain and S-124 
layer in disease remains unclear, several possibilities exist to explain their functional role. 125 
One explanation is that modification to the S-layer alters the capacity of the bacteria to 126 
adhere to the epithelial barrier, limiting proximity and impact of localized toxin on release. 127 
This would reduce the overall impact of toxins on both barrier integrity and inflammasome 128 
activation and hence limit tissue damage and disease. While this is feasible, the equivalence 129 
of toxins detected in filtered gut washes from RDD2 versus WT infected animals and the 130 
epithelial cellular susceptibility to purified toxins, suggests this explanation is unlikely.  131 
Alternatively, reduction in disease severity seen in mice infected with RΔD2 may be linked to 132 
failure of host cells to effectively signal an immune response. The evidence that TLR (Toll-133 
like receptor) signaling is important in C. difficile disease is now significant, with several 134 
studies showing that signaling through a MyD88 dependent pathway is essential in immune 135 
protection21,22. The S-layer has been implicated in activation of this pathway through 136 
activation of TLR423 and it is tempting to speculate that the D2 domain is important for this 137 
function. In vitro, S-layer signaling in both mouse and human dendritic cells induces the 138 
production of proinflammatory cytokines including IL-23, and enhances the activity of the 139 
toxin-activated inflammasome23. However, as MyD88 and TLR4 -/- mice appear more 140 
susceptible to disease, the failure of the modified S-layer (SlpARΔD2) to signal through this 141 
pathway should lead to enhanced disease. This is in contrast to our results, in which animals 142 
infected with RDD2 showed reduced pathology. 143 
 7 
Another possibility is that modifications in S-layer-mediated signaling influences the 144 
downstream generation of specific proinflammatory cytokines such as IL-23. Infection of IL-145 
23 -/- mice with C. difficile resulted in limited tissue edema, reduced inflammatory influx 146 
and less epithelial damage24; mirroring the observations in animals infected with the 147 
modified RΔD2 strain in this study.  Further, in vitro, a combination of cell filtrates and toxin 148 
but not toxin alone, was required to stimulate the expression of IL-23 in both mouse and 149 
human bone marrow-derived macrophages25. As these filtrates are likely to contain high 150 
levels of SlpA, it could be speculated that IL-23 expression relies on two independent 151 
signals, the first provided by the toxin (through inflammasome activation) and the second, a 152 
MyD88-dependent event implicating TLR signaling, possibly involving SlpA.  Therefore, if the 153 
D2 domain is essential for TLR signaling, reduction of disease could be linked to prevention 154 
of downstream IL-23 mediated events such as enhancement of inflammation and sustained 155 
barrier damage.  156 
 While the specific mechanism by which S-layer is able to modify the severity of toxin 157 
mediated-disease is currently unclear, we now have the tools and structural knowledge to 158 
allow us to dissect and determine the relevance of the S-layer structure in C. difficile 159 
disease.   160 
  161 
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Sequence alignment of representatives of each S-layer Cassete Type (SLCT) using CD630 as a reference. Secondary structural elements identified in 
the H/L CD630 complex (PDB ID: 7ACY) are indicated by looped lines – α-helices and arrows – β-sheets. SLPL D1, D2 and LID domains and SLPH HID 
domain and CWB2 motifs are highlighted, colored as in Fig. 1. Residues involved in the interactions depicted in Extended Data Fig. 4a are marked as 
per key, with interacting residues marked with the same color. Analysis of conservation of both residue and potential interaction across these SlpA 
variants is summarised in the clustermap in Extended Data Fig. 4b. Strictly conserved residues across all SLCTs are highlighted in black background, 
similar (partially conserved) groups are delimited by a box, with residues conserved within each group highlighted in bold, as per default in ESPript31 
(http://espript.ibcp.fr). Reference SLCT7 - strain CD630; SLCT1 - strain 1912; SLCT2 - strain Ox858; SLCT3 - Ox1121; SLCT4 - strain R20291; SLCT5 - 
Ox1437a; SLCT6 - strain 19123; SLCT6/H2 - strain M120; SLCT7b - R7404; SLCT8 - Ox1396; SLCT9 - strain TL178; SLCT10 - strain Liv22; SLCT11 - strain 
Ox247; SLCT 12 - strain CD062; SLCT13 - strain 19142. Bold indicates strains with structural models included in this work.  
 
1 Robert et al. Nucleic Acids Res. 42, W320–W324, 2014 
Table 1 - Data collection and refinement statistics 
 
 LID/HID SLPL/HID 
H/L R7404 
S-SAD 
H/L R74041 H/L CD630 HっL RらDヲ 
Data collection       
Space group C2  C2 P21 P21 P1 P1 
Cell dimensions       
    a, b, c (Å) 
73.3, 56.7, 
61.8 
172.9, 29.5, 
144.3 
76.7, 134.7, 
83.9 
78.1, 137.9, 
84.7 
72.7, 78.3, 
81.6 
52.8, 80.4, 
81.9 
    üが éが ɶ (°)  90.0, 122.7, 
90.0 
90.0, 94.2, 
90.0 
90.0, 100.8, 
90.0 
90.0, 100.7, 
90.0 
81.9, 67.0, 
65.3 
97.0, 90.2, 
90.2 
Wavelength (Å) 0.975 0.969 2.755 0.928 0.969 0.969 
Resolution (Å) 
41.74- 1.50   
(1.55-1.50) 
86.20-2.40  
(2.49-2.40) 
47.70-3.00 
(3.16-3.00) 
83.26-2.65 
(2.75-2.65) 
52.30-2.55 
(2.65-2.55) 
52.74-3.50 
(3.63-3.50) 
IっゝI 8.1 (2.3) 5.5 (1.9) 16.5 (1.2) 12.0 (1.4) 7.0 (1.5) 10.0 (2.5) 
CC1/2 
0.998 
(0.975) 
0.979 
(0.713) 
0.998 
(0.707) 
0.712 
(0.360) 
0.992 
(0.732) 
0.616 
(0.438) 
Completeness (%) 99 (97) 100 (100) 91 (80) 100 (100) 96 (97) 99 (97) 
Redundancy 3.4 (2.6) 5.1 (5.2) 6.4 (6.1) 48.0 (43.0) 3.3 (3.4) 3.4 (3.5) 
Anomalous 
completeness 
  91.2 (79.7)    
Anomalous 
multiplicity 
  3.3 (3.3)    
       
Refinement       
Resolution (Å) 41.74- 1.50 86.20-2.40  83.26-2.65 52.50-2.55 52.74-3.50 
No. reflections 33987 29330  51027 47183 16607 
Rwork / Rfree 18.1/21.0 25.2/30.1  22.6/27.8 23.0/25.7 28.4/31.4 
No. atoms       
    Protein 1709 3477  9945 10306 7890 
    Ligand/ion - -  40 15 5 
    Water 107 217  111 97 7 
B-factors       
    Protein 33.11 42.01  71.87 60.21 38.01 
    Ligand/ion - -  71.79 123.30 94.83 
    Water 37.55 39.32  59.43 45.98 8.48 
Ramachandran %       
     favoured 100.0 98.2  97.2 98.5 96.4 
     allowed ( 0.0 1.8  2.6 1.5 3.6 
     outliers (%) 0.0 0.00  0.4 0.00 0.0 
R.m.s. deviations       
    Bond lengths (Å) 0.009 0.005  0.007 0.007 0.006 
    Bond angles (°) 1.14 0.98  1.19 1.11 0.97 
PDB ID 7ACW 7ACV  7ACX 7ACY 7ACZ 
*Values in parentheses are for highest-resolution shell. 
1Two crystals were used to determine the structure of H/L complex R7404. All others required one crystal 
only. 
 
 
 
Table 2 - EM data and reconstruction statistics 
 
 SlpAR20291 SlpARлDヲ 
3D merging statistics 
(EM reconstructions;  
negative staining) 
 
 
 
Resolution limit (Å) 20 20 
No. structure factors 1085 667 
Overall R-factor 0.33 0.33 
Overall phase residual (°) 22.3 13.9 
   
Phase residuals in CryoEM 
projections 
(p2-averaged Fourier terms) 
  
No. independent phases 
   Resolution shell (Å) 
    з に 15   
    15 - 11 
    11 - 8.7 
    8.7 に 7.5 
 
 
43 
42 
47 
44 
 
 
43 
42 
45 
- 
Mean value phase error* 
   Resolution shell (Å) 
    з に 15   
    15 - 11 
    11 - 8.7 
    8.7 に 7.5 
 
 
15.3 
22.9 
32.2 
36.8 
 
 
21.5 
28.7 
33.8 
- 
Standard error (°) 
   Resolution shell (Å) 
    з に 15   
    15 - 11 
    11 - 8.7 
    8.7 に 7.5 
 
 
2.4 
2.8 
3.6 
3.9 
 
 
3.5 
4.1 
3.6 
- 
   
*Mean value phase error against symmetry-imposed phase of 0° or 180° (45° is expected for random 
phases 1). 
 
  
Table 3 ʹ Symmetry table for cryo-EM reconstruction of SlpAR20291 
 
Plane Group 1 Phase residual (°) 
(random = 90°) 
Target residual 2 (°) 
p1 27.0 - 
p2* 37.5 39.7 
p12b 77.6 29.8 
p12a 55.1 29.8 
p121b 57.2 29.8 
p121a 51.0 29.8 
c12b 77.6 29.8 
c12a 55.1 29.8 
p222 67.7 33.6 
p2221b 52.7 33.6 
p2221a 47.5 33.6 
p2221a 62.2 33.6 
c222 67.7 33.6 
p4 46.8 33.6 
p422 61.9 30.1 
p4212 63.5 30.1 
p3 52.5 27.0 
p312 60.4 27.7 
p321 63.0 28.5 
p6 50.4 31.6 
p622 58.1 29.3 
*Represents most likely plane group  
1a and b represent the respective symmetry axis for the plane group 
2Target residual indicates the expected phase residual of each symmetry group based on the signal-to-
noise ratio of the respective reflections 2. 
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